Itraconazole for invasive fungal infection with pediatric malignancies

Pediatrics International

Volumn 52, Issue 5, 2010, Pages 707-710

  Kobayashi, Ryoji ^a   Suzuki, Daisuke ^a   Yasuda, Kazue ^a   Kobayashi, Kunihiko ^a  

^a SAPPORO HOKUYU HOSPITAL   (Japan)

Author keywords

invasive fungal infection; itraconazole

Indexed keywords

IRINOTECAN; ITRACONAZOLE; VINCRISTINE SULFATE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; DRUG BLOOD LEVEL; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INAPPROPRIATE VASOPRESSIN SECRETION; INFANT; LIVER DYSFUNCTION; MALE; MYCOSIS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROPHYLAXIS;

ADMINISTRATION, ORAL; ADOLESCENT; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; FUNGEMIA; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; ITRACONAZOLE; JAPAN; LUNG DISEASES, FUNGAL; MALE; PEDIATRICS; PRIMARY PREVENTION; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77957333771     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03127.x     Document Type: Article

References (9)

1. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin. Infect. Dis. 2002 34 : 7 14.
2. Kobayashi R, Kaneda M, Sato T, Ichikawa M, Suzuki D, Ariga T. The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: A 10-year analysis at a single institution at Japan. J. Pediatr. Hematol. Oncol. 2008 30 : 886 890.
3. Kume H, Yamazaki T, Abe M, Tanuma H, Okudaira M, Okayasu I. Epidemiology of visceral mycoses in patients with leukemia and MDS: Analysis of the data in annual of pathological autopsy cases in Japan in 1989, 1993, 1997 and 2001. Jpn. J. Med. Mycol. 2006 47 : 15 24.
4. Koch S, Hohne FM, Tietz HJ. Incidence of systemic mycoses in autopsy material. Mycoses 2004 47 : 40 6.
5. Kieren AM, Rachel AC, Fulvio C, Anna W, Lawrence C. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 2002 34 : 909 917.
6. Menichetti F, Del Favero A, Martino P et al. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: A randomized, placebo-controlled, double-blind, multicenter trial. Clin. Infect. Dis. 1999 28 : 250 255.
7. Morgenstern GR, Prentice AG, Prentice HG, Ropner JE, Schey SA, Warnock DW. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group. Br. J. Haematol. 1999 105 : 901 911.
8. Glasmacher A, Prentice AG. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies. J. Antimicrob. Chemother. 2005 56 (Suppl. 1 i23 32.
9. Rex JH, Pfaller MA, Bartlett MS et al. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin. Infect. Dis. 1997 24 : 235 247.